James E. Rowedder

691 total citations
19 papers, 460 citations indexed

About

James E. Rowedder is a scholar working on Immunology and Allergy, Molecular Biology and Oncology. According to data from OpenAlex, James E. Rowedder has authored 19 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology and Allergy, 9 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in James E. Rowedder's work include Cell Adhesion Molecules Research (10 papers), Platelet Disorders and Treatments (4 papers) and Peptidase Inhibition and Analysis (4 papers). James E. Rowedder is often cited by papers focused on Cell Adhesion Molecules Research (10 papers), Platelet Disorders and Treatments (4 papers) and Peptidase Inhibition and Analysis (4 papers). James E. Rowedder collaborates with scholars based in United Kingdom, Ireland and United States. James E. Rowedder's co-authors include Marjorie A. Smith, Jeffrey J. Clare, Koti Sreekrishna, Robert J. Slack, Simon J. F. Macdonald, John W. Barrett, Panayiotis A. Procopiou, Peter N. Lowe, Richard Skinner and John M. Pritchard and has published in prestigious journals such as Analytical Biochemistry, Journal of Medicinal Chemistry and Chemistry - A European Journal.

In The Last Decade

James E. Rowedder

19 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James E. Rowedder United Kingdom	9	299	61	60	58	45	19	460
Gisele Tavares France	9	254 0.8×	81 1.3×	55 0.9×	71 1.2×	34 0.8×	11	601
Andreas Knapp Germany	14	414 1.4×	65 1.1×	44 0.7×	26 0.4×	67 1.5×	27	685
Luciano Puzer Brazil	15	329 1.1×	63 1.0×	47 0.8×	50 0.9×	51 1.1×	31	665
Jon J. Schmuke United States	11	238 0.8×	27 0.4×	23 0.4×	85 1.5×	74 1.6×	14	373
Suneal K. SREEDHARAN United Kingdom	10	221 0.7×	28 0.5×	90 1.5×	95 1.6×	32 0.7×	24	454
Wenjun Liu United States	14	564 1.9×	71 1.2×	14 0.2×	86 1.5×	58 1.3×	23	861
Maurice S. Brozzo Switzerland	6	343 1.1×	89 1.5×	17 0.3×	23 0.4×	83 1.8×	7	432
Thakor Patel Norway	8	508 1.7×	60 1.0×	53 0.9×	52 0.9×	72 1.6×	9	636
Giada Marino Germany	18	538 1.8×	76 1.2×	43 0.7×	21 0.4×	25 0.6×	33	856
Rosemary Condron Australia	16	613 2.1×	70 1.1×	134 2.2×	32 0.6×	96 2.1×	20	811

Countries citing papers authored by James E. Rowedder

Since Specialization

Citations

This map shows the geographic impact of James E. Rowedder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Rowedder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Rowedder more than expected).

Fields of papers citing papers by James E. Rowedder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Rowedder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Rowedder. The network helps show where James E. Rowedder may publish in the future.

Co-authorship network of co-authors of James E. Rowedder

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Rowedder. A scholar is included among the top collaborators of James E. Rowedder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Rowedder. James E. Rowedder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Barrett, John W., Glenn A. Burley, Richard J. D. Hatley, et al.. (2024). Core Modifications of GSK3335103 toward Orally Bioavailable α_vβ₆ Inhibitors with Improved Synthetic Tractability. Journal of Medicinal Chemistry. 67(21). 19689–19715. 3 indexed citations

Procopiou, Panayiotis A., John W. Barrett, Richard J. D. Hatley, et al.. (2024). Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic α_vβ₆ Integrin Inhibitors. Journal of Medicinal Chemistry. 67(19). 17497–17519. 1 indexed citations

Burton, Amy, James E. Rowedder, Jonathan P. Hutchinson, et al.. (2022). A high-throughput MALDI-TOF MS biochemical screen for small molecule inhibitors of the antigen aminopeptidase ERAP1. SLAS DISCOVERY. 28(1). 3–11. 8 indexed citations

Barrett, John W., et al.. (2020). Discovery of the first potent and selective αvβ5 integrin inhibitor based on an amide-containing core. European Journal of Medicinal Chemistry. 208. 112719–112719. 8 indexed citations

Rowedder, James E., et al.. (2020). Late‐Stage Functionalization by Chan–Lam Amination: Rapid Access to Potent and Selective Integrin Inhibitors. Chemistry - A European Journal. 26(34). 7678–7684. 9 indexed citations

Chung, Chun‐wa, M.A. Convery, Craig Jamieson, et al.. (2020). Design and Development of a Macrocyclic Series Targeting Phosphoinositide 3-Kinase δ. ACS Medicinal Chemistry Letters. 11(7). 1386–1391. 9 indexed citations

Barker, Daniel, Panayiotis A. Procopiou, John W. Barrett, et al.. (2019). Profile of a Highly Selective Quaternized Pyrrolidine Betaine α_vβ₆ Integrin Inhibitor—(3S)-3-(3-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-4-((1S and 1R,3R)-1-methyl-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-ium-1-yl)butanoate Synthesized by Stereoselective Methylation. Journal of Medicinal Chemistry. 62(16). 7543–7556. 6 indexed citations

Hatley, Richard J. D., Robert J. Slack, Anna Gruszka, et al.. (2019). The Design of Potent, Selective and Drug‐Like RGD αvβ1 Small‐Molecule Inhibitors Derived from non‐RGD α4β1 Antagonists. ChemMedChem. 14(14). 1315–1320. 6 indexed citations

Anderson, Niall A., Sébastien Campos, Royston C. B. Copley, et al.. (2019). Discovery of an Orally Bioavailable Pan αv Integrin Inhibitor for Idiopathic Pulmonary Fibrosis. Journal of Medicinal Chemistry. 62(19). 8796–8808. 8 indexed citations

10.

Procopiou, Panayiotis A., Niall A. Anderson, John W. Barrett, et al.. (2018). Discovery of (S)-3-(3-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-4-((R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic α_vβ₆ Integrin Inhibitor for the Inhaled Treatment of Idiopathic Pulmonary Fibrosis. Journal of Medicinal Chemistry. 61(18). 8417–8443. 31 indexed citations

11.

Convery, M.A., Anthony W. J. Cooper, Kenneth Down, et al.. (2018). Discovery of Potent, Efficient, and Selective Inhibitors of Phosphoinositide 3-Kinase δ through a Deconstruction and Regrowth Approach. Journal of Medicinal Chemistry. 61(24). 11061–11073. 10 indexed citations

12.

Procopiou, Panayiotis A., Alison J. Ford, Simon T. Hodgson, et al.. (2017). Design of Phthalazinone Amide Histamine H₁ Receptor Antagonists for Use in Rhinitis. ACS Medicinal Chemistry Letters. 8(5). 577–581. 12 indexed citations

13.

Kellam, Barrie, Stephen J. Hill, Nicholas D. Kindon, et al.. (2017). Design and Elaboration of a Tractable Tricyclic Scaffold To Synthesize Druglike Inhibitors of Dipeptidyl Peptidase-4 (DPP-4), Antagonists of the C–C Chemokine Receptor Type 5 (CCR5), and Highly Potent and Selective Phosphoinositol-3 Kinase δ (PI3Kδ) Inhibitors. Journal of Medicinal Chemistry. 60(4). 1534–1554. 8 indexed citations

14.

Rowedder, James E., et al.. (2017). Determining the True Selectivity Profile of αv Integrin Ligands Using Radioligand Binding: Applying an Old Solution to a New Problem. SLAS DISCOVERY. 22(8). 962–973. 14 indexed citations

15.

Procopiou, Panayiotis A., Ashley P. Hancock, Simon T. Hodgson, et al.. (2016). The discovery of quinoline based single-ligand human H1 and H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 26(24). 5855–5859. 6 indexed citations

16.

Tipping, William J., James Truslow Adams, James E. Rowedder, et al.. (2014). Relative Binding Affinities of Integrin Antagonists by Equilibrium Dialysis and Liquid Chromatography–Mass Spectrometry. ACS Medicinal Chemistry Letters. 6(2). 221–224. 5 indexed citations

17.

Healy, Mark P., Gianpaolo Bravi, Andrew Billinton, et al.. (2010). Pyrazolopyridazine alpha-2-delta-1 ligands for the treatment of neuropathic pain. Bioorganic & Medicinal Chemistry Letters. 20(15). 4683–4688. 12 indexed citations

18.

Skinner, Richard, et al.. (1994). Direct Measurement of the Binding of RAS to Neurofibromin Using a Scintillation Proximity Assay. Analytical Biochemistry. 223(2). 259–265. 22 indexed citations

19.

Clare, Jeffrey J., et al.. (1991). Production of mouse epidermal growth factor in yeast: high-level secretion using Pichia pastoris strains containing multiple gene copies. Gene. 105(2). 205–212. 282 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact